# Dextromethorphan in Fibromyalgia

> **NCT03538054** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 27 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Dextromethorphan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03538054
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-26
- **Primary completion:** 2020-03-18
- **Final completion:** 2020-03-18
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538054, "Dextromethorphan in Fibromyalgia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03538054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*